JPS55143971A - 144methoxymorphinann66one compound - Google Patents

144methoxymorphinann66one compound

Info

Publication number
JPS55143971A
JPS55143971A JP4207580A JP4207580A JPS55143971A JP S55143971 A JPS55143971 A JP S55143971A JP 4207580 A JP4207580 A JP 4207580A JP 4207580 A JP4207580 A JP 4207580A JP S55143971 A JPS55143971 A JP S55143971A
Authority
JP
Japan
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4207580A
Other languages
English (en)
Inventor
Kumaaru Razudan Raji
Chiyandora Gooshiyu Aniru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sisa Inc
Original Assignee
Sisa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sisa Inc filed Critical Sisa Inc
Publication of JPS55143971A publication Critical patent/JPS55143971A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • C07D221/28—Morphinans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP4207580A 1979-04-24 1980-04-02 144methoxymorphinann66one compound Pending JPS55143971A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/032,733 US4272540A (en) 1979-04-24 1979-04-24 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them

Publications (1)

Publication Number Publication Date
JPS55143971A true JPS55143971A (en) 1980-11-10

Family

ID=21866524

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4207580A Pending JPS55143971A (en) 1979-04-24 1980-04-02 144methoxymorphinann66one compound

Country Status (7)

Country Link
US (1) US4272540A (ja)
JP (1) JPS55143971A (ja)
CA (1) CA1136130A (ja)
DE (1) DE3004170A1 (ja)
FR (1) FR2455048A1 (ja)
GB (1) GB2045758A (ja)
IL (1) IL59287A0 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009263367A (ja) * 2002-07-03 2009-11-12 Alcasynn Pharmaceuticals Gmbh １４位が置換されたモルフィナン誘導体、その第四級アンモニウム塩、それらの製造方法及び使用

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260617A (en) * 1979-12-17 1981-04-07 Sisa, Incorporated 17-Cyclopropylmethyl-14-hydroxy-3-methoxymorphinan-6-one and method of treating pain with it
US4370333A (en) * 1981-06-29 1983-01-25 Sisa, Incorporated 17-Cyclopropylmethyl-3-hydroxy-14-methoxy 7α-methyl-morphinan-6-one and therapeutic method of treating pain with it
US4362733A (en) * 1981-06-29 1982-12-07 Miles Laboratories, Inc. N-Cyclopropylmethyl-14-ethoxymorphinan-6-one compounds exhibiting mixed analgesic/narcotic antagonist activity and precursors therefore
US5878750A (en) * 1996-11-14 1999-03-09 Clemens; Anton H. Method of treating the syndrome of coronary heart disease risk factors in humans
US6846831B2 (en) 2000-08-15 2005-01-25 Cpd, Llc Method of treating the syndrome of lipodystrophy
US6262062B1 (en) * 2000-08-15 2001-07-17 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
US6528520B2 (en) * 2000-08-15 2003-03-04 Cpd, Llc Method of treating the syndrome of coronary heart disease risk factors in humans
TWI365880B (en) * 2004-03-30 2012-06-11 Euro Celtique Sa Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
AU2005286733B2 (en) * 2004-09-23 2009-11-05 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
SI2724722T1 (sl) 2006-10-20 2017-07-31 Neurendo Pharma, Llc Postopek za obnovitev učinka inkretina
CA2738246C (en) * 2008-09-30 2017-09-05 Mallinckrodt Inc. Processes for the alkylation of secondary amine groups of morphinan derivatives
CN107405343A (zh) 2014-11-07 2017-11-28 明尼苏达大学董事会 可用于治疗疾病的盐和组合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3654280A (en) * 1968-03-21 1972-04-04 Shionogi & Co L-n allylic-3-hydroxy-6-oxomorphinans
BE788478A (fr) * 1971-09-08 1973-03-06 Bristol Myers Co Procede de preparation de composes analgesiques
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives
DE2538075A1 (de) * 1975-08-27 1977-03-17 Boehringer Sohn Ingelheim N-tetrahydrofurfuryl-noroxymorphone, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung
US4089855A (en) * 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
US4161597A (en) * 1976-12-20 1979-07-17 Research Corporation N-alkyl-14-hydroxymorphinans and derivatives
US4141897A (en) * 1976-12-20 1979-02-27 Research Corporation N-dealkylation of N-alkyl-14-hydroxymorphinans and derivatives thereof
CA1093070A (en) * 1978-02-10 1981-01-06 Michael P. Kotick 8.beta.-ALKYL-SUBSTITUTED MORPHINAN-6-ONE COMPOUNDS
US4232028A (en) * 1979-06-18 1980-11-04 Sisa, Incorporated 17-Cyclobutylmethyl-4,5α-epoxy-3-hydroxy-14-methoxy-8α-methylmorphinan-6-one, and method of treating pain with it

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009263367A (ja) * 2002-07-03 2009-11-12 Alcasynn Pharmaceuticals Gmbh １４位が置換されたモルフィナン誘導体、その第四級アンモニウム塩、それらの製造方法及び使用

Also Published As

Publication number Publication date
IL59287A0 (en) 1980-05-30
FR2455048A1 (fr) 1980-11-21
CA1136130A (en) 1982-11-23
GB2045758A (en) 1980-11-05
US4272540A (en) 1981-06-09
DE3004170A1 (de) 1980-12-04

Similar Documents

Publication Publication Date Title
GB2052478B (en) Guanidinothiazole compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
JPS55124743A (en) 99aminoalkylfluorene compound
JPS55143971A (en) 144methoxymorphinann66one compound
JPS55111255A (en) Compound structure
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS55136288A (en) Betaalactam contained compound
JPS567790A (en) Novel penicillinn1*11dioxide compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
JPS5667369A (en) Phthaloperinone compound
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
ZA802765B (en) Novel compounds
JPS55136264A (en) Pyridineacetoamide compound
GB2047708B (en) Butyloctyl-magnesium compounds
JPS55147293A (en) Novel thiazolinoazetidinone compound
JPS55124648A (en) Compound structure
IL61133A0 (en) 6-methylene-morphinan compounds
JPS5632575A (en) Antiifreeze compound
JPS56100858A (en) Halootriazinyl compound
ZA807948B (en) 2-oxybenzimidazoline compounds
JPS55130958A (en) Benzenesulfinamide compound